Magnetic Drug Delivery: An Alternative to Surgery and Needle Based Procedure-Abhita Batra, MS, MBA-02/06/2018 - 8:30am

Event Information
Event Topic: 
Magnetic Drug Delivery: An Alternative to Surgery and Needle Based Procedure
Event Date: 
02/06/2018 - 8:30am
Event Location: 
Sunnyvale City Council Chambers- 456 West Olive Ave., Sunnyvale
Speaker Information
Event Speaker: 
Abhita Batra, MS, MBA
Event Speaker Title: 
Chief Business Officer
Event Speaker Company: 
Event Speaker Bio: 

Abhita Batra serves as the Chief Business Officer at Otomagnetics. Abhita is the Co-Founder and Managing Director of Advanced Biopharma Consulting (ABC), a strategic advisory firm that offers business development, and commercialization services to pharmaceutical, biotechnology and medical device industries.

Previously, she served as the Vice President of Business Development and Marketing at Admac Group of Companies, wherein she managed a product portfolio encompassing 150 generics, including antibiotics and oncology drugs, and was instrumental in setting up an ISO-9001 and WHO-GMP certified, 40,000 sq. feet oncology manufacturing facility in 2012. She is a Co-Founder and former COO of Navya Biomedical Technologies, a biotechnology company developing and commercializing PHF for destruction of solid tumors.

Abhita has recognized proficiency in tackling complex challenges of US and global markets and significant expertise in raising funds through high net worth individuals, angel investors and Venture Capital firms. She completed her Global MBA at UCLA Anderson and NUS, and has a Masters in Biotechnology with specialization in Pharmaceutical Sciences from University of Pennsylvania.

Event Details
Event Details: 

Otomagnetics' technology uses magnetic fields to deliver therapy to targets in the body that are either unreachable by current medical standards-of-care, or would otherwise require an invasive surgery to reach. The company is first pursuing conditions of the ear, eye, and skin. Instead of tympanostomy tube surgery for recurrent or chronic middle ear conditions (the most common pediatric surgery in the United States), our magnetic injection system can deliver therapy into the middle ear without tubes or surgery. Magnetic injection can also deliver orders of magnitude more therapy to the cochlea as compared to current standards of care. It can deliver therapy into the eye without needle injections. Currently there are no effective treatments for hearing loss, tinnitus, or to protect hearing from chemotherapy regimens; and treatments for recurrent/chronic middle ear infections and eye macular degeneration are invasive (surgery, needles in the eye). The technology uses magnetic fields to achieve non-invasive delivery. In pre-clinical studies it has shown an improved therapeutic effect for middle ear infections, hearing loss, tinnitus, and protection of hearing from chemotherapy regimens.

In this talk, Abhita will be presenting about Otomagnetics's technology as well as discussing the clinical markets that will be served.